Vitrolife AB (publ)
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VTRLY research report →
About the company
Vitrolife AB (publ) is a Swedish medical technology company, established in 1994 and headquartered in Gothenburg. Its core business involves the development, manufacturing, and distribution of specialized products catering to assisted reproductive technologies (ART). The company offers a comprehensive portfolio that includes essential tools for the in vitro fertilization (IVF) process, such as oocyte retrieval needles, solutions for sperm preparation, and advanced IVF culture media and oils.
- CEO
- Bronwyn Brophy O'Connor
- IPO
- 2016
- Employees
- 1,150
- HQ
- Gothenburg, SE
Price Chart
- Market Cap
- $1.54B
- P/E
- -2.46
- P/S
- 3.62
- P/B
- 1.53
- EV/EBITDA
- -2.86
- Div Yield
- 1.21%
- Gross Margin
- 51.41%
- Op Margin
- 18.04%
- Net Margin
- -147.21%
- ROE
- -47.11%
- ROIC
- 5.74%
- Revenue
- $3.44B · -4.68%
- Net Income
- $-4,711,229,716 · -1018.37%
- EPS
- $-34.79 · -1017.94%
- Op Income
- $579.03M
- FCF YoY
- -62.17%
- 52W High
- $18.55
- 52W Low
- $9.50
- 50D MA
- $10.95
- 200D MA
- $13.33
- Beta
- 1.72
- Avg Volume
- 13
Get TickerSpark's AI analysis on VTRLY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our VTRLY coverage
Recent articles, reports, and earnings notes.
No research on VTRLY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VTRLY report →Similar companies
Peers in the same neighborhood.